First Wave BioPharma Inc (FWBI)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -217.143 | -181.396 | -209.035 | -185.414 | -299.372 | -473.723 | -173.812 | -261.37 |
Return on Equity (%) | 6998.561 | -455.314 | -441.206 | -333.913 | -3306.883 | 1119.059 | 589.604 | -507.581 |
Return on Invested Capital (%) | 2367.647 | -395.8 | -419.046 | -318.934 | -2716.833 | 1066.584 | 491.205 | -502.822 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -0.041 | -0.141 | 0.112 | -0.025 | -0.243 | -0.655 | 0.167 | 0.142 |
Earnings Per Share | -1.515 | -0.921 | -0.764 | -0.566 | -1.049 | -3.94 | -2.36 | -1.193 |
Cash Per Share | 0.184 | 0.048 | 0.063 | 0.007 | 0.195 | 0.555 | 0.215 | 0.275 |
Working Capital Per Share | 0.065 | -0.044 | 0.102 | -0.033 | -0.246 | -0.194 | 0.147 | 0.135 |
Operating Profit Per Share | 0.031 | N/A | N/A | N/A | N/A | N/A | 1.274 | N/A |
EBIT Per Share | -1.515 | -0.921 | -0.764 | -0.566 | -1.049 | -3.94 | -2.306 | -1.17 |
EBITDA Per Share | -1.515 | -0.921 | -0.764 | -0.566 | -1.049 | -3.94 | -2.306 | -1.17 |
Free Cash Flow Per Share | -1.59 | -0.981 | -0.792 | -0.582 | -1.067 | -3.282 | -2.364 | -1.195 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 9,63M | 12,04M | 17,71M | 26,8M | 31,15M | 14,86M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | 4,21M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2M |
Ratio cours/bénéfice | -0,12 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,54 |
Ratio prix/valeur comptable | 0,55 |
Rendement de dividende | - |
Actions en circulation | 675k |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales